UBS Group’s Accendra Health ACH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $323K | Sell |
94,395
-214,339
| -69% | -$666K | ﹤0.01% | 6500 |
|
|
2026
Q1 | $704K | Sell |
308,734
-519,760
| -63% | -$1.2M | ﹤0.01% | 5823 |
|
|
2025
Q4 | $2.32M | Buy |
828,494
+234,675
| +40% | +$839K | ﹤0.01% | 4835 |
|
|
2025
Q3 | $2.85M | Sell |
593,819
-174,407
| -23% | -$1.11M | ﹤0.01% | 4631 |
|
|
2025
Q2 | $6.99M | Buy |
768,226
+311,389
| +68% | +$2.29M | ﹤0.01% | 3510 |
|
|
2025
Q1 | $4.13M | Buy |
456,837
+317,336
| +227% | +$3.35M | ﹤0.01% | 3985 |
|
|
2024
Q4 | $1.82M | Buy |
139,501
+55,894
| +67% | +$745K | ﹤0.01% | 4810 |
|
|
2024
Q3 | $1.31M | Buy |
83,607
+30,105
| +56% | +$456K | ﹤0.01% | 4395 |
|
|
2024
Q2 | $722K | Sell |
53,502
-22,080
| -29% | -$452K | ﹤0.01% | 4710 |
|
|
2024
Q1 | $2.09M | Sell |
75,582
-7,639
| -9% | -$170K | ﹤0.01% | 3908 |
|
|
2023
Q4 | $1.6M | Buy |
83,221
+77,771
| +1,427% | +$1.41M | ﹤0.01% | 4041 |
|
|
2023
Q3 | $88.1K | Sell |
5,450
-34
| -0.6% | -$603 | ﹤0.01% | 5912 |
|
|
2023
Q2 | $104K | Sell |
5,484
-94,794
| -95% | -$1.69M | ﹤0.01% | 5983 |
|
|
2023
Q1 | $1.46M | Buy |
100,278
+5,054
| +5% | +$90.5K | ﹤0.01% | 3755 |
|
|
2022
Q4 | $1.86M | Buy |
95,224
+49,888
| +110% | +$973K | ﹤0.01% | 3460 |
|
|
2022
Q3 | $1.09M | Buy |
45,336
+21,401
| +89% | +$659K | ﹤0.01% | 3679 |
|
|
2022
Q2 | $753K | Sell |
23,935
-15,473
| -39% | -$561K | ﹤0.01% | 3958 |
|
|
2022
Q1 | $1.74M | Sell |
39,408
-4,627
| -11% | -$199K | ﹤0.01% | 3571 |
|
|
2021
Q4 | $1.92M | Sell |
44,035
-108,929
| -71% | -$4.27M | ﹤0.01% | 3773 |
|
|
2021
Q3 | $4.79M | Buy |
152,964
+95,920
| +168% | +$3.78M | ﹤0.01% | 2719 |
|
|
2021
Q2 | $2.41M | Sell |
57,044
-1,280
| -2% | -$49.8K | ﹤0.01% | 3408 |
|
|
2021
Q1 | $2.19M | Sell |
58,324
-86,887
| -60% | -$2.72M | ﹤0.01% | 3478 |
|
|
2020
Q4 | $3.93M | Buy |
145,211
+83,735
| +136% | +$2.15M | ﹤0.01% | 2711 |
|
|
2020
Q3 | $1.54M | Sell |
61,476
-23,021
| -27% | -$336K | ﹤0.01% | 3302 |
|
|
2020
Q2 | $644K | Sell |
84,497
-19,558
| -19% | -$143K | ﹤0.01% | 3935 |
|
|
2020
Q1 | $952K | Sell |
104,055
-33,366
| -24% | -$201K | ﹤0.01% | 3397 |
|
|
2019
Q4 | $711K | Buy |
137,421
+54,435
| +66% | +$350K | ﹤0.01% | 4526 |
|
|
2019
Q3 | $483K | Buy |
82,986
+21,856
| +36% | +$98K | ﹤0.01% | 4590 |
|
|
2019
Q2 | $196K | Buy |
61,130
+34,496
| +130% | +$118K | ﹤0.01% | 4926 |
|
|
2019
Q1 | $110K | Sell |
26,634
-156,983
| -85% | -$993K | ﹤0.01% | 5000 |
|
|
2018
Q4 | $1.16M | Sell |
183,617
-90,785
| -33% | -$942K | ﹤0.01% | 3528 |
|
|
2018
Q3 | $4.53M | Buy |
274,402
+61,962
| +29% | +$1.05M | ﹤0.01% | 2438 |
|
|
2018
Q2 | $3.55M | Buy |
212,440
+166,733
| +365% | +$2.7M | ﹤0.01% | 2641 |
|
|
2018
Q1 | $711K | Sell |
45,707
-64,567
| -59% | -$1.15M | ﹤0.01% | 3970 |
|
|
2017
Q4 | $2.08M | Buy |
110,274
+18,570
| +20% | +$412K | ﹤0.01% | 3157 |
|
|
2017
Q3 | $2.68M | Sell |
91,704
-35,145
| -28% | -$1.04M | ﹤0.01% | 2839 |
|
|
2017
Q2 | $4.08M | Buy |
126,849
+23,425
| +23% | +$769K | ﹤0.01% | 2337 |
|
|
2017
Q1 | $3.58M | Buy |
103,424
+17,464
| +20% | +$624K | ﹤0.01% | 2389 |
|
|
2016
Q4 | $3.03M | Buy |
85,960
+22,043
| +34% | +$745K | ﹤0.01% | 2536 |
|
|
2016
Q3 | $2.22M | Buy |
63,917
+18,630
| +41% | +$652K | ﹤0.01% | 2745 |
|
|
2016
Q2 | $1.69M | Buy |
45,287
+36,962
| +444% | +$1.39M | ﹤0.01% | 2914 |
|
|
2016
Q1 | $336K | Sell |
8,325
-1,269
| -13% | -$47.3K | ﹤0.01% | 4094 |
|
|
2015
Q4 | $346K | Buy |
9,594
+6,367
| +197% | +$230K | ﹤0.01% | 4235 |
|
|
2015
Q3 | $103K | Buy |
3,227
+51
| +2% | +$1.74K | ﹤0.01% | 5211 |
|
|
2015
Q2 | $108K | Sell |
3,176
-1,585
| -33% | -$53.4K | ﹤0.01% | 5338 |
|
|
2015
Q1 | $161K | Sell |
4,761
-6,546
| -58% | -$228K | ﹤0.01% | 5044 |
|
|
2014
Q4 | $397K | Buy |
+11,307
| New | +$381K | ﹤0.01% | 4388 |
|
Other funds holding ACH
CCM
ICM
PCMI
UBS Group's ACH Position: Q2 2026 in Review
UBS Group reduced its Accendra Health (ACH) stake by 69% in Q2 2026, selling an estimated $666K and leaving 94,395 shares worth $323K. The position accounts for ﹤0.01% of the portfolio, ranked #6500.
UBS Group first reported a position in ACH in Q4 2014 and has held it in 47 quarters since. The position peaked at $6.99M in Q2 2025. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.
- UBS Group held 94,395 shares of Accendra Health worth $323K as of Q2 2026.
- UBS Group sold 214,339 Accendra Health shares in Q2 2026, an estimated $666K.
- Accendra Health made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6500 holding.
- UBS Group first reported a position in Accendra Health in Q4 2014 and has held it in 47 quarters since.
- UBS Group's Accendra Health position peaked at $6.99M in Q2 2025.
- 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.